| Gyselaers, Wilfried |
| Completed | N/A | 1095 | Europe | Telemonitoring, Longitudinal CV profiling during pregnancy and before and after the start/switch of antihypertensive medication, CV profiling before and after the start/switch of antihypertensive medication | Hasselt University, Ziekenhuis Oost-Limburg, Universitaire Ziekenhuizen KU Leuven, AZ Sint-Jan AV, AZ Sint-Lucas Brugge, University Hospital, Antwerp | Gestational Hypertension | 02/24 | 02/24 | | |
| Recruiting | N/A | 2000 | Europe | remote monitoring | Hasselt University, Ziekenhuis Oost-Limburg | Pregnancy, Pre-eclampsia | 12/30 | 12/30 | | |
| Humblet, Evelien |
| Completed | 4 | 200 | Europe | 5-ASA | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW, Ferring Pharmaceuticals | Ulcerative Colitis | 02/24 | 02/24 | | |
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy |
|
|
| Recruiting | 4 | 292 | Europe | Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab | Universitaire Ziekenhuizen KU Leuven | Crohn Disease | 10/27 | 10/30 | | |
| Robaeys, Geert |
| Recruiting | N/A | 300 | Europe | screening: HCV RNA test and risk factors questionaire | Hasselt University | Drug Use, Hepatitis C | 10/21 | 10/21 | | |
| Recruiting | N/A | 100 | Europe | Blood sampling, questionaires | Hasselt University, Ziekenhuis Oost-Limburg, Jessa Hospital, Algemeen Ziekenhuis Vesalius, CAD Limburg, Sint-Trudo, Free Clinic Antwerp, Ziekenhuis Netwerk Antwerpen (ZNA), Clinique Saint Joseph, Liège, Centre Hospitalier Universitaire Saint Pierre, Algemeen Ziekenhuis Maria Middelares | Hepatitis C Virus Infection, Response to Therapy of, Drug Use | 02/22 | 02/22 | | |
| Active, not recruiting | N/A | 150 | Europe | Determination of the economic burden NAFLD patients | Hasselt University | Non-Alcoholic Fatty Liver Disease, NAFLD | 04/24 | 04/24 | | |
NCT04999124: Characteristics of NAFLD Among Type 2 Diabetes Patients |
|
|
| Active, not recruiting | N/A | 3000 | Europe | Screening and studying characteristics | Ziekenhuis Oost-Limburg, Ziekenhuis Oost-Limburg | Non-Alcoholic Fatty Liver Disease, Type2 Diabetes | 05/25 | 05/25 | | |
| Recruiting | N/A | 10000 | Europe | screening | Hasselt University | Non-Alcoholic Fatty Liver Disease | 12/24 | 12/24 | | |
| Recruiting | N/A | 300 | Europe | Coach, App, Standard of care | Ziekenhuis Oost-Limburg | Non-Alcoholic Fatty Liver Disease | 11/25 | 11/25 | | |
| Active, not recruiting | N/A | 156 | Europe | Cessation of ongoing treatment | University Hospital, Antwerp, Universiteit Antwerpen | Chronic Hepatitis B | 12/25 | 12/25 | | |
| Recruiting | N/A | 1000 | Europe | Non-invasive diagnostic testing | Ziekenhuis Oost-Limburg | NAFLD, ACS - Acute Coronary Syndrome | 04/26 | 04/26 | | |
| Mullens, Wilfried |
EASY-HF, NCT06278792: Readily Available Urinary Sodium Analysis in Patients With Acute Decompensated Heart Failure |
|
|
| Completed | N/A | 60 | Europe | Diuretic protocol, Standard of Care | Ziekenhuis Oost-Limburg, Fund for Scientific Research, Flanders, Belgium | Acute Decompensated Heart Failure | 07/23 | 01/24 | | |
NCT04688827: Impact of Additional Resistance Training During Rehabilitation Therapy in Patients With Heart Failure |
|
|
| Not yet recruiting | N/A | 30 | Europe | Exercise therapy | Hasselt University, Ziekenhuis Oost-Limburg | Heart Failure | 01/23 | 01/23 | | |
| Active, not recruiting | N/A | 457 | Europe, US | Cordella™ Pulmonary Artery Sensor System | Endotronix, Inc. | Heart Failure NYHA Class III | 04/28 | 04/28 | | |
ReQUAD-HF, NCT06273280: Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction. |
|
|
| Active, not recruiting | N/A | 345 | Europe | SOC, Protocolized up-titration | Ziekenhuis Oost-Limburg, King Baudouin Foundation | Heart Failure, Heart Failure With Reduced Ejection Fraction | 12/25 | 03/26 | | |
| Recruiting | N/A | 470 | Europe, RoW | Left ventricular septal pacing, Right ventricular pacing | Maastricht University, ZonMw: The Netherlands Organisation for Health Research and Development, Medtronic | Cardiac Pacing, Pacing-Induced Cardiomyopathy, Conduction System Pacing, Left Ventricular Septal Pacing, Atrioventricular Block | 05/25 | 05/25 | | |
| Recruiting | N/A | 82 | Europe, RoW | Biventricular pacemaker implantation, Conduction system pacing device implantation, AV node ablation | University Medical Centre Ljubljana | Heart Failure, Tachycardia-induced Cardiomyopathy, Atrial Fibrillation | 12/25 | 12/26 | | |
| Lansink, Wouter |
HEAL, NCT04110327: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease |
|
|
| Recruiting | N/A | 300 | Europe | MicroStent | Micro Medical Solution, Inc. | Peripheral Arterial Disease, Critical Lower Limb Ischemia | 12/26 | 12/28 | | |
| Active, not recruiting | N/A | 160 | Europe | Ballon expandable stent and PTA | Biotronik AG | Peripheral Artery Disease | 02/23 | 02/28 | | |
SUPERSURG-RCT, NCT04349657: A Study Evaluating the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy |
|
|
| Recruiting | N/A | 286 | Europe | Supera Peripheral Stent System treatment group, Endarterectomy treatment group | ID3 Medical | Peripheral Arterial Disease | 09/26 | 09/28 | | |
PRIZER, NCT04546477: Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease |
|
|
| Active, not recruiting | N/A | 135 | Europe | Stent implantation | Terumo Europe N.V. | Superficial Femoral Artery Disease, Popliteal Artery Disease | 06/24 | 06/26 | | |
NCT06758921: Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First) |
|
|
| Recruiting | N/A | 200 | Europe | Oscar Peripheral Multifunctional Catheter | Biotronik AG | Peripheral Arterial Disease, Peripheral Arterial Disease(PAD) | 12/25 | 01/26 | | |
QBX-RADAR, NCT05799131: Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) |
|
|
| Not yet recruiting | N/A | 100 | Europe | QBX (5F/6F) Peripheral Balloon Expandable Stent System | QualiMed Innovative Medizinprodukte GmbH | Peripheral Arterial Disease | 06/25 | 07/25 | | |
BARISTA, NCT05293002: Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. |
|
|
| Active, not recruiting | N/A | 131 | Europe | Restorer Iliac Stent System | ID3 Medical | Peripheral Arterial Disease | 07/25 | 12/25 | | |
| Recruiting | N/A | 204 | Europe | ESAR treatment: Endograft + Heli-FX Endoanchor, FEVAR treatment : Fenestrated endograft | FCRE (Foundation for Cardiovascular Research and Education), Medtronic | Aortic Aneurysm, Abdominal | 06/26 | 06/28 | | |
ILICO, NCT05192616: Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease |
|
|
| Not yet recruiting | N/A | 214 | Europe | Covered stent implantation | iVascular S.L.U. | Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent, Aorto-Iliac Atherosclerosis | 05/24 | 05/25 | | |
| Baert, Didier |
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy |
|
|
| Recruiting | 4 | 292 | Europe | Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab | Universitaire Ziekenhuizen KU Leuven | Crohn Disease | 10/27 | 10/30 | | |
| Completed | 2 | 153 | Europe, Canada, US | TAK-062, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar, TAK-062 Placebo, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar | Takeda | Celiac Disease | 11/24 | 11/24 | | |
| Nauwelaers, Sigi |
NCT05473299: Xeltis Hemodialysis Access Graft: aXess Pivotal Study |
|
|
| Recruiting | N/A | 110 | Europe | Xeltis Hemodialysis Access (aXess) graft | Xeltis | End-stage Renal Disease | 01/25 | 06/29 | | |
| Vrolix, Matthias |
| No trials found |
| Lierde, Johan Van |
| No trials found |
